Earnings Feed
Start Free
Home/Insiders/Patel Priti
PP
SEC Insider//CIK 0001859997

Patel Priti

CIK 00018599971 companySEATTLE, WA
SEC Profile

Transactions

14

Companies

1

Filings

7

CIK

0001859997

Recent Transactions

14 trades
  • Sale
    Neurogene Inc.$NGNE

    Common Stock

    2023-04-03$0.69/sh−3,769→ 37,313 total
  • Exercise/Conversion
    Neurogene Inc.$NGNE

    Common Stock

    2023-03-31+10,000→ 41,082 total
  • Exercise/Conversion
    Neurogene Inc.$NGNE

    Restricted Stock Units

    2023-03-31−10,000→ 0 total
  • Sale
    Neurogene Inc.$NGNE

    Common Stock

    2023-02-02$0.60/sh−14,380→ 31,082 total
  • Exercise/Conversion
    Neurogene Inc.$NGNE

    Common Stock

    2023-02-01+35,000→ 45,462 total
  • Exercise/Conversion
    Neurogene Inc.$NGNE

    Restricted Stock Units

    2023-02-01−35,000→ 35,000 total
  • Award
    Neurogene Inc.$NGNE

    Stock Option (Right to Buy)

    2022-08-02+250,000→ 250,000 total
  • Sale
    Neurogene Inc.$NGNE

    Common Stock

    2022-05-02$1.22/sh−5,538→ 6,462 total
  • Exercise/Conversion
    Neurogene Inc.$NGNE

    Restricted Stock Units

    2022-04-30+10,000→ 10,000 total
  • Exercise/Conversion
    Neurogene Inc.$NGNE

    Common Stock

    2022-04-30+10,000→ 12,000 total
  • Award
    Neurogene Inc.$NGNE

    Restricted Stock Units

    2022-02-01+70,000→ 70,000 total
  • Award
    Neurogene Inc.$NGNE

    Stock Option (Right to Buy)

    2021-08-03+50,000→ 50,000 total
  • Award
    Neurogene Inc.$NGNE

    Restricted Stock Units

    2021-04-30+20,000→ 20,000 total
  • Award
    Neurogene Inc.$NGNE

    Stock Option (Right to Buy)

    2021-04-30+475,000→ 475,000 total

Companies

1

Recent Filings

7

Address

C/O NEOLEUKIN THERAPEUTICS, INC. 188 EAST BLAINE STREET, #450

SEATTLE, WA, 98102

View on SEC.gov